Serratia marcescens infections.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001170:Arthritis, Infectious / Q000382:microbiology; D003428:Cross Infection / Q000382:microbiology* / Q000635:transmission; D004352:Drug Resistance, Microbial; D004697:Endocarditis, Bacterial / Q000382:microbiology; D004756:Enterobacteriaceae Infections / Q000382:microbiology* / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D010019:Osteomyelitis / Q000382:microbiology; D010860:Pigments, Biological / Q000096:biosynthesis; D012141:Respiratory Tract Infections / Q000382:microbiology*; D012706:Serratia marcescens / Q000145:classification / Q000187:drug effects / Q000378:metabolism / Q000472:pathogenicity*; D013530:Surgical Wound Infection / Q000382:microbiology; D014552:Urinary Tract Infections / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D010860:Pigments, Biological